Literature DB >> 19329861

Pathology of intracranial germ cell tumors.

Kazufumi Sato, Hiroaki Takeuchi, Toshihiko Kubota.   

Abstract

Intra cranial germ cell tumors (GCTs) usually arise in midline structures, including the pineal or suprasellar regions of children and young adults. The classification of GCTs includes germinoma, teratoma, yolk sac tumor, embryonal carcinoma, and choriocarcinoma. However, intracranial GCTs are often of mixed histologic composition (mixed GCTs), and only germinoma and teratoma are likely to be encountered as pure tumor types. Although GCTs are usually identified using conventional histological techniques, immunohistochemical studies are very useful for delineating these entities, using special markers such as human chorionic gonadotropin, alpha-fetoprotein, human placental alkaline phosphatase, cytokeratin, as well as c-kit and OCT4. Ultrastructural examination is also useful in confirming the identity of these tumors. Genetic alterations specifically encountered in central nervous system GCTs are largely unknown. Patients with Klinefelter syndrome or Down syndrome appear to be predisposed to the development of gonadal as well as intracranial germinomas. Frequent imbalances of chromosomes have been described in intracranial GCTs, including chromosomes 1, 8, 12, 13, 18 and X. Recently, p14 and c-kit gene alterations have been reported, particularly in some intracranial germinomas; however, their importance remains unclear. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329861     DOI: 10.1159/000210053

Source DB:  PubMed          Journal:  Prog Neurol Surg        ISSN: 0079-6492


  14 in total

Review 1.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

2.  Tumor cells forming sinusoids connected to vasculature are involved in hemorrhage of pineal choriocarcinoma.

Authors:  Song-tao Qi; Hui Zhang; Ye Song; Jia-lin Zhang
Journal:  J Neurooncol       Date:  2014-05-22       Impact factor: 4.130

3.  Mixed malignant germ cell tumour of third ventricle with hydrocephalus: a rare case with recurrence.

Authors:  Manjari Kishore; Vidya Monappa; Lakshmi Rao; Ranjini Kudva
Journal:  J Clin Diagn Res       Date:  2014-11-20

4.  HESRG: a novel biomarker for intracranial germinoma and embryonal carcinoma.

Authors:  Siyi Wanggou; Xingjun Jiang; Qiaoyu Li; Lihua Zhang; Dingyang Liu; Guifei Li; Xiangling Feng; Weidong Liu; Bin Zhu; Wei Huang; Jia Shi; Xianrui Yuan; Caiping Ren
Journal:  J Neurooncol       Date:  2011-08-23       Impact factor: 4.130

5.  A suprasellar germ cell tumor in a 16-month-old Wagyu heifer calf.

Authors:  Aimee N Brooks; Kelly N Brooks; Michael J Oglesbee
Journal:  J Vet Diagn Invest       Date:  2012-05       Impact factor: 1.279

6.  Apparent diffusion coefficient of intracranial germ cell tumors.

Authors:  Hideki Ogiwara; Yoshiyuki Tsutsumi; Kentarou Matsuoka; Chikako Kiyotani; Keita Terashima; Nobuhito Morota
Journal:  J Neurooncol       Date:  2014-11-21       Impact factor: 4.130

7.  Primary cranial vault germinoma in a 23-year-old man: illustrative case.

Authors:  Christopher Lauren; Donny Argie; Elric B Malelak; Reza Mawardy; Samuel E Suranta; Vito M Junaidy; Yohanes Firmansyah
Journal:  J Neurosurg Case Lessons       Date:  2021-04-05

8.  Primary choriocarcinoma of the liver: a clinicopathological study of five cases in males.

Authors:  Huaiyin Shi; Dengfeng Cao; Lixin Wei; Lu Sun; Aitao Guo
Journal:  Virchows Arch       Date:  2009-12-16       Impact factor: 4.064

9.  Imaging diagnosis of basal ganglia germ cell tumors: subtype features subtype imaging features of GCTs.

Authors:  Wei Li; Xin Kong; Jun Ma
Journal:  Br J Radiol       Date:  2021-04-29       Impact factor: 3.629

10.  Primary intracranial germ cell tumors.

Authors:  Shagufta Tahir Mufti; Awatif Jamal
Journal:  Asian J Neurosurg       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.